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EXECUTIVE SUMMARY
Chemical warfare agents present an obvious risk to individuals suffering
acute exposure, but they may also present long-term environmental or
occupational health hazards for workers in operations involving these
chemical agents. Occupational health standards have not been established for
Lewisite (L) [dichloro(2-chlorovinyl)arsine] a potent vesicant which reacts
with sulfhydryl groups of proteins through its arsenic group. Lewisite is
used in a number of research laboratories, stored in depot sites throughout
the country and occasionally transported to distant sites. The destruction
of current stockpiles of Lewisite by the U.S. Army in the near future could
create additional environmental and occupational risk. To establish a data-
base for setting environmental and occupational standards, we conducted
studies to evaluate the toxicity, mutagenicity, and reproductive effects of
Lewisite using in vitro and in vivo study systems.
The cytotoxic, clastogenic mutagenic effects of Lewisite in Chinese
hamster ovary cells were investigated and are described in this report. One
mutation assay and two cytogenetic assays were used in this study. The
mutation assay utilized the hypoxanthine-guanine phyosphoribosyl transferase
(HGPRT) locus (6-thioguanine resistance). The two cytogenetic analyses were
chromosomal aberration analysis, measurement of chromosome damage, and sister
chromatid exchange (SCE), a measurement of chromosome redrrangement.
The CHO cells were exposed in the test system for I hour, then washed
and culture$ for an additional 20-30 hours, depending on the assay to be
used. The total number of mutant colonies were determined and the mutation
frequency was calculated. Chromosome aberrat.ions were scored using 100
metaphases per dose and SCE per cell were calculated. (SOW) . -- .
One hour exposures to Lewisite were cytotoxic in #14 amounts. The cell
survival response yielded a D37 of 0.5 #14 and an extrapolation number of 2.5.
The mutagenic response at the HGPRT locus was sporadic and not significantly
greater than control values when cells were exposed over a range of 0.12 to
2.0 #14. Sister chromatid exchange (SCE) induction, a measure of chromosomal
rearrangement, was weakly positive over a range of 0.25 to 1.0 O14 but the
values were not significantly greater than the control response. Chromosomal
aberrations were induced at 0.50, 0.75 and 1.0 #14 in one experiment and 0.50
3
and 0.75 #M4 in another experiment. The induced values were significantly
greater than the control values. Lewisite appeared to be cytotoxic and
clastogenic in our investigations but SCE and mutation at the HGPRT locus
were not significantly greater than control values. Lewisite toxicity was in
some ways similar to radiomimetic chemicals such as bleomycin.
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INTRODUCTION
Chemical warfare agents present an obvious risk to individuals suffering
acute exposure but they may also present long-term environmental or
occupational health hazards for workers in operations involving these
chemical agents. Lewisite [dichloro(2-chlorovinyl)arsine], one of two major
vesicant agents, presents a potential for accidental or occupational exposure
because it is used in a number of research laboratories, stored in depot
sites throughout the country and occasionally transported to distant sites.
In addition, stockpiles of Lewisite are scheduled for destruction by the U.S.
Army in the near future, creating an additional potential for environmental
and occupational exposure. Although considerable information is known
concerning the acute effects of Lewisite, few data are available on its long-
term hazards. Segments of the population that may be particularly sensitive
to its toxicity include the chronically .'11, the young and old, and the
unborn. It is this concern that has prompted these studies to identify the
potentially toxic, mutagenic and reproductive effects of Lewisite and to
establish a database for the development of hazard evaluations and
occupational health standards for this chemical.
Lewisite is a highly toxic chemical vesicant. Unlike the strong
alkylating vesicant sulfur mustard, Lewisite reacts with the sulfhydryl
groups of proteins through its arsenic group (Cassarett and Doull, 1986). In
the presence of water or alkalies, Lewisite hydrolyzes to form Lewisite
oxide, which is non-volatile and insoluble in water. Although few data are
available, Lewisite oxide is generally thought to be a weaker vesicant (Gates
et al., 1946) but its toxicity has yet to be determined. Relevant chemical
and physical data for Lewisite are summarized In Table 1.
A comprehensive review which summarized the chemical and toxicity data
of Lewisite acquired during World War I and World War II was published in
1946 (Gates et al., 1946). This review compared known human and animal data
and concluded that sufficient toxicologic data were available for the
determination of military usage. Lewisite exposure is characterized by
immediate onset of pain, unlike the action of sulfur mustard in which pain
may be delayed. The mucus membranes of the respiratory and gastrointestinal
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TABLE 1. Relevant Chemical and Physical Data for Lewisite,
0ichloro(2-chlorovinyl)arsinea
Cas #: 541-25-3
RTECS C: 0H2975000
Structural formula: Cl -CH=CH-AsCl2
Molecular weight: 207.3 g
Density at 20°C: 1.888 g/ml
State: Dark, oily liquid
(stable in steel and glass)
Vapor pressure at 200C: 0.394 m
Decomposition temperature: >1000C
Solubility in water: Very slightly soluble
Hydrolysis
Rate: Rapid
Products: Chlorovinyl arsenous oxide, HC1
(in acid solutions)
Acetylene, sodium arsenate
(in alkaline solutions)
aRosenblatt et f1. 1975
tracts are particularly sensitive to Lewisite damage. Lewisite is not only a
lethal vesicant but is also a systemic toxin; the liver, kidneys, gall
bladder, bile duct and other organ systems are vulnerable to damage if
absorption occurs (Cameron et al. 1946).
Exposures to Lewisite vapor produces edema of the respiratory tract and
accumulation of pleural fluid (Gates, et al., 1946). Skin lesions resulting
from contact with liquid Lewisite involve the rapid formation of an
erythematous area, subs.-.quent vesication and penetration of subcutaneous
tissue so that edema and necrosis are evident. Man was less sensitive to
skin lesion induction than the dog or rabbit. Systemic intoxication was
evident in the dog a few hours following application of Lewisite (Gates et
al., 1946). Although sufficient anatomical lesions to characterize the
imediate cause of death were not #.pparent, it was reported that fluid losses
due to changes in capillary permeability did cause remarkable decreases in
blood volume. Comparisons of toxic effects of Lewisite and sulfur mustard in
dogs and rabbits indicated that Lewisite was more damaging to the skin and
was more likely to Induce systemic poisoning than was sulfur mustard.
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Few data are available to evaluate the potential chronic effects of
Lewisite other than informattott based on anecdotal evidence from war use.
based on one incidence of accidental exposure to a soldier's leg, Lewisive is
considered a suspect carcinogen in man (Krause and Grussendorf, 1978).
Workers of a Japanese factory producing mustard and Lewisite agents during
World War II had a high mortality rate due to respiratory and gastro-
intestinal cancers (Wada et al., 1968; Yamakido et al., 1985). These workers
were potentially exposed to unknown quantities of both sulfur mustard and
Lewisite; therefore, it is not possible to Implicate Lewisite as a carcinogen
because of poszibie confounding effects of the carcinogen sulfur mustard.
Virtually no data were found on the mutagenicity of Lewisite in tile
literature. Auerbach (1947) found no mutvjenic response in the fruit fly
exposed to Lewisite and Loveless (1951) reported normal cellular division in
root tips exposed to aqueous solutions of Lewisite. The teratogenic
potential of Lewisite was studied by Hackett et al. (1987) in rats and
rabbits using a segment II teratology protocol. Rats were exposed to 0.5,
1.0 or 1.5 mg/kg Lewisite via gastric intubation from 6 to 15 days of
gestation (dg) and fetuses were examined on dg 20. No evidence of a
teratogenic response to Lewisite was observed. Likewise, fetal development
of the rabbit exposed to 0.07 to 0.6 mg/kg Lewisite between 6 and 19 dg was
n.-t affected even though maternal mortality was induced. These results
suggest that Lewisite is not teratogenic in the rat or %he rabbit after short
term exposures since fetal effects were observed only at dose levels that
induced maternal toxicity.
It is of interest that many of the symptoms of Lewisite and arsenic
intoxication are similar (severe inflammation of thie gastrointestinal tract
with electrolyte disturbances and ulceration and perforation of membranes)
(NAS, 1977) and raise the possibility that the toxicity of Lewisite may
result from its arsenic group. In alkaline ;olutions, Lewisite may hydrolyzo
to form acetylene and sodium arsenate. Leonard and Lauwerys (1980) reviewed
the carcinogenicity, teratogenicity and mutagenicity of a wide variety of
arsenic compounds. Arsenic, as sodium arsenate or arsenite, is known to be
embryotoxic and teratogenic in a number of animal species (Leonard and
Lauwerys, 1980). In a comparison of Lewisite and sodium arsenite toxicity in
the rabbit following intravenous administration, Inns et al. (1988) reported
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that the LDO is of sodium arsenite and Lewisite were not similar (7.6 and
1.8 mg/kg, respectively). Furthermore, significant differences in tissue
arsenic content and pathology were reported for the two chemicals.
Very little information is available ci the effects of Lewisite using in
vitro, mamalian cell systems. However, the mutagenicity of arsenic
compounds in vitro has been reviewed (Leonard and Louwerys, 1980). in
general all of the arsenic compounds investigated in mamalian cell systems
produced chmsowal aberrations. No information is available for mutation
induction in mmmalian system, although arsenic compounds were analyzed in
bacterial systems and some were mutagenic while ot*hers were not. We report
here on the cytotoxicity, mutagenicity, and also the clastogenicity of
Lewiste using Chinase hanster ovary (CHO) cells.
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MATERIALS AND METHODS
LeWisite
Procurement and Characterization
A shipment of 25 *l of dichloro(2-chlorovinyl)arsine (!ewisite, Agent L)
was received from the U.S. Ar-ay Medical Research Institute of Chemical
Defense (USAMRICD) on 7 March 1985. The chemical (Lot No. L-U-4273-CTF-N)
was prepared by distillation on 30 September 1984 at the Chemical Research
and Development Center (CRDC). The agent was analyzed by nuclear magnetic
resonance (H-1 and C-13; CROC SOP No. 8-1-83-1, Annex F) at the Research
Directorate, CROC. Results of the analyses, expressed as calculated weight
percent, were 95.8 and 4.0 for trans and cis isomers of dichloro(2-
chlorovinyl)arsine, respectively, and 0.2 for unknown compounds.
The Lewisite was divided into two equal portions, pipetted into 30-ml
Wheaton vials, sealed and stored in secondary unbreakable containers In
refrigerat6. storage at '"6C. To comply with Good Laboratory Practices
rcquirments, PHL requested that USAMRICD retain an aliquot of this lot of
Lewisite.
Lewisite was analyzed on 20 January 1986 to detect the presence of
common impurities, such as Lewisite oxide and the cis-trans isomers of bis(2-
chlorovinyl)chloroarsine and tris(2-chlorovinyl)arsine (Rosenblatt et al.,
1975). Measurement ol the ultraviolet absorption spectrum of the sample in
isooctane revealed that the spectrum and the absorptivity of the material at
215 nm agreed with published values in the literature (Rewick, et al., 1986;
Mohler and Sorge, 1939) and did not indicate the presence of ultraviolet-
bsorbing compounds other than Lewisite. This conclusion was supported by
our results from gas-chromatographic analyses of the sample following
derivatization with 2-mercaptoethanol.
Selection and Characterization of Diluent
Lewisite is relatively insoluble and a;so is rapidly hydrolyzed in
water; therefore, absolute ethanol (EtOH) was emp!oyed as the diluent for
dosing solutions in this study.
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Lewisite in EtON was assayed by gas chromatography, using a capillarl
column and flame-ionization detection. Lewisite was prepared by the addition
of 2-mercaptoethanol; the ieaction, which proceeds at room temperature, may
be written:
CICH-CHAsCl2 + 2 HSCH 2CH2 OH ClCH-CHAs(SCH 2CH OH)2 + 2HCl
In the procedure developed for the analysis, Lewisite samples were diluted
1:10 with isooctane prior to analysis. For the assay, 1.0 ml of the sample
was diluted with 0.5 ml of a solution containing 112 ng of 1-chloron-
aphthalene and 5584 ng of 2-mercaptoethanol/pl in isooctane contained in a
1.5 ml automatic sampler vial with a Teflon-lined, crimped-top cap. The
column (J&W Scientific, 08-5) temperature program was 90°C for 5 min (5W/li)
to 1406C, 20°/min to 3000C and 3000C for 40 min. A Hewlett-Packard 5840A gas
chromatograph and a 7672A automatic sample changer were used.
The results were within acceptable limits of analytical error fo-
concentrations greater than 0.5 mg/ml. As the Lewisite concentrations in the
solutions decreased, the assay results became less acceptable. The method
was not sufficiently sensitive to detect concentrations of Lewisite below 0.1
mg/ml. Lewisite was stable in EtOH at concentrations above the detection
limit for at least one day; all exposures were conducted within 24 hours of
preparation of Lewisite solutions.
Chemicals Used
Dilutions of the Lewisite were made up in absolute (punctilious) ethanol
(EtOH - U.S. Industrial Chemical Co.). A new bottle of ethanol was used for
each experiment. Ethyl methanesulfonate (EMS - Sigma lot #95F-0226) was used
as a positive control for mutation and sister chromatid exchange (SCE)
studies. EMS proved inadequate as a positive control for aberration analysis
and bleomycin (Sigma Lot #37F-0888) was substituted. All EMS dilutions were
made up in absolute ethanol. 6-aminocrysine (6-AC: Aldrich lot #092797) was
used as a positive control for materials that required S9 activation. 6-AC
was solubilized in dimethylsulfoxide (INSO: American Type Culture, Lot
#129341). Metabolic activation was accomplished using Litton Bionetics rat
12
liver S9 preparation lot #07420. The 6-thioguanine (6-TG: Sigma lot #15f-
4023), used as a selecting chemical in the hypoxanthine-guanirne phosphor,-
bosyl transferase (HGPRT) mutation assay, was made up in sterile water as a 3
mM stock solution and used at a final concentration in sedium of 30 p'.
5-Brom-2' -deoxytridine (Brd Urd: Sigma lot 056F-0767 and #35F-0089),
Hoechst dye (Sigma lot #106F-0458 and #25F-3538), and Giemsa stain (Gurr's
improved R66 lot #772201) were used to differentiate sister chromatids. The
Sorensen's buffer used in this technique was made up as a lOX solution (A and
B stock). Stock A - 9.07g K H2P0 4 in 100 ml H20; Stock 8 - 9.47 g NatHP0 4 in
100 ml H20. The final working solution was 10 ml A and 10 al B brought up to
103 iv!s total with dH2 ) and the pH was adjusted to 6.8.
Cell Culture Media
F12 medium supplemented with 5% fetal bovine serum (fbs) was used for
routine cell culture. F12 medium - hypoxanthine (-HX) supplemented with 5%
dialyzed fetal bovine serum (dfbs) was used for mutant selection.
Identification of Cell Line
The cells used in this study were designated CHO/C18 which was a
subclone of CHO used for mutation analysis (Jostes et a., 1980). These
cells have been subsequently maintained in liquid nitrogen and cultured in
F12 medium supplemented with 5% fetal bovine serum. Cell identification was
routinely verified using chromosome analysis. Chr.omsom analysis included
showing that the man chromosom number was 21 and that the karyotype was
consistent with CHO cells.
In Vitro Assays
One mutation assay and two cytogenetic assays were used in this study.
The mutation assay utilized the HGPRT locus (6-thioguanine resistance). The
two cytogenetic analyses were chromsomal aberration analysis (a measurement
of chromosome damage) and SCE (a measurement of chromosome rearrangement).
The experimental design for each was as follows:
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Ihtatict Analysis
In addition to the test compound, the CHO/HGPRT mutation assay contained
the following elements; a positive control (EMS); a promutagen (6-AC) which
required metabolic activation and a solvent control (Et0H) which served as a
negative control. Three concentrations of the test compound were assayed in
replicate or triplicate. CiHO cells were treated in 75 cat tissue culture
flasks. Cells (0.5 - 1.0 x 108 per flask) were plated into 10 ml F12 medium
with 5% fetal calf serum (fcs) and were incubated for 15-24 hours before
exposure. The test compound was diluted in EROH and a standard volume (50
p1) was added to 10 ml of F12 medium minus serum for cell exposure. Direct-
acting mutagens were added to 10 60 of F12 medium - fbs and incubated at 370C
for 1 hour a 5 min.
Rat liver microsomes (S9) were used in some experiments to activate
prmtagens. In this case the S9 and associated cofactors were added to the
medium just before treatment.
After treatment cultures were washed 3 times with saline G and fresh F12
+ 5% fbs was added to the cultures. The cells were then incubated for an
additional 20-30 hours before trypsinization to alleviate possible trypsin
effects. After trypsinization the cells were plated for initial survival
(day 1) and for phenotypic expression (6-10 days). At the end of the
expression period the cells were trypsinized and replated into F12 -Hx + 5'
dfbs for determination of plating efficiency and 5 x 10' cells/well were
plated into 3, 6-well plates containing F12 -Hx, 30 pH 6-TG and 5' dfbs for
selection of mutant colonies.
After colony formation the plates were fixed, stained, and counted. The
total number of mutant colonies and the plating efficiency was determined at
each treatment. The mutation frequency was then calculated by dividing the
total number of mutant colonies by the cells plated into 6-TG corrected for
plating efficiency.
Cytogenetic Analysis
Treatment protocols were as described previously for the mutation
analysis. After treatment the cells were cultured for at least 24 hours in
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F12 medium supplemented with 5% fbs for aberration analysis. If the
chromosomes were to be scored for SCE, 10 #M BrdUrd was present in the medium
after treatment. After approximately 24 hours colcemid was added at a final
concentration of 0.08 pg/ml. Metaphase cells were collected by the *shake"
method and the suspended cells were centrifuged, swelled, fixed and burst
onto microscope slides. Cells were prepared for aberration analysis by
staining in 5% Giemsa. Chromosomes were prepared for SCE analysis by a
modification of the methodology of Perry and Wolff (1974).
Statistical Analysis
Chr•osom aberrations were scored using 100 metaphases per dose. In
aberration studies each cell was evaluated as an individual treatment and
means and standard errors are calculated within each experiment. Standard
error is used because of the high number of naught values in each treatment
and the poisson nature of aberration distribution. The standard error was
determined by the formula: square root of the mean numer of aberrations
divided by the square root of the number of metaphases evaluated (Bradley et
al. 1981).
SCE were scored and the data is expressed as SCE/cell. Analysis of 30
metaphases/treatment was made and significant differences were determined
using the more conventional standard deviations (Remington, 1970).
Criteria for a positive mutation response were evaluated according to
the genetox reports of Bradley et al., (1981). That is, any responsm 3 X the
appropriate spontaneous value was taken to be positive.
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RESULTS
Cytotoxicity
Figure 1 presents the CHO cell survival response (day 1) for 1 hour
Lewisite exposures as determined by colony formation in two experiments.
Using the data from experiment B a Da of approximately 0.5 /A4 '-wisite and
an extrapolation number of 2.5 was derived. When the cells were exposed in
the presence of S9 microsomal fractions, the survival was enhanced suggesting
that the S9 itself interferes with Lewisite toxicity (Figure 2).
Mutation Results
Initially, a dose range of 0.12 A1 to 1.0 #14 was selected for mutation
analysis (Table 2, experiment A). This represents essentially the first
decade of survival. Because the metabolic requirements of Lewisite are
unknown S9 microsomal fractions were included in a replicate set of
exposures. In this experiment the only mutation frequency that exceeded
control values was at the highest exposure dose without S9 (1.0 pm).
Accordingly, a higher dose range of 0.5 to 2.0 #M was selected for the second
experiment (Table 2, experiment 8). In this experiment the only value above
spontaneous was the 1.0 #H exposure with S9. In both cases in which the
frequencies were above spontaneous values the variation of the control and
treated frequencies suggest that they are not significantly different.
Sister Chromatid Exchange
Table 3 presents data which show a small increase in chromosomal
rearrangement (SCE) at all of the dose levels investigated with the exception
of 0.5 pM (experiment C) and 0.25 #M4 + $9 (experiment 0). In no case how-
ever, were the treatment values significantly greater than the spontaneous
values as determined by standard deviations. Furthermore, no value was
greater than 56% above the spontaneous value nor was a concentration related
increase observed over at least 3 concentrations.
17
.01
.01
-I\
Dm)
.. 0
.001 ,
0 1 2 3
uM Lewlsfte
Figure 1. Fraction of cells surviving Lewisite treatment (day 1).
Circles are from experiment A and squares are from
experiment B. The line was dravwn by eye to the data 'rom
experiment 8.
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Figure 2. Fraction of cells surviving Lewisite treat&met in the presence of
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The lino was drawn by eye to the data from experiment B. Note the
increase in survival compared to that without S9 (see Figure 1).
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Clastogenic Effects
A dose range of 0.25 to 1.0 p1 Lawisite was selected for the aberration
experie-Ats based on survival results. This represents a ;urvival range of
30 to 100 percent. Table 4 presents data from two experiments. In both
experiments a threshold was seen above which aberration frequencies were
significantly greater than control values. When cells were exposed to
Lewisite in the presence of S9 (experiment E) a significant increase was not
apparent. Because of this result and a similar inhibition of cytotoxicity
(Figure 2) we did not include S9 in experiment F. The absolute toxicity (as
judged by metaphase recovery and aberration induction) was greater in
experiment F. Significant increases (P < 0.05) in aberrations were observed
at 0.5, 0.75, and 1.0 A14 Lewisite in experiment E and 0.5 and 0.75 am4
Lewisite in experiment F as judged by standard error.
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DISCUSSION
Lewisite induced chroosomal aberrations at micromolar exposure levels.
Convwrsely, SCE were not observed in statistically !ignificant numbers. In
this regard, Lewisite is similar to bleopycin, a radiomimetic, antineoplastic
agent. One interpretation of this observation would be that the action of
the two igents might be similar. We have noted in this report tnat
significant levels of mutations are not observed at the HGPRT locus. It is
tempting to suggest that Lewisite affects the DNA in :uch a way that all
"hits* are lethal. It is known, however, that bleomycin is a weak mutagen at
the HGPRT locus and a strong mutagen at the L5178Y TK locus. A popular
interpretation of this observation is that lesions induced by bleomycin
affect many loci (multilocus deletions, translocations) and that tie first
lethal gene lies close to the 1GPRT gene but is further removed from the TK
locus in L5178Y cells.
In any case, chr.msomal aberrations are often lethal events and no
doubt contritute to cell death after Lewisite exposure. Whether or not the
agent is mutagenic may require investigations at other loci, such as the
L5178Y TK system. In at least one gene situation, CHO - HGPRT, Lewisite is
not mutagenic over the first decade of survival.
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